Navigation Links
Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
Date:4/21/2009

$898.7 million in the prior fiscal year. Sales of Lexapro (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder in adults and, most recently, adolescents and generalized anxiety disorder in adults were $548.5 million, a decline of 5.0% from the year-ago period. Sales of Namenda(R), an NMDA receptor antagonist for the treatment of moderate and severe Alzheimer's disease, totaled $243.8 million in the quarter, an increase of 7.7% from last year's fourth quarter. Sales of Bystolic(TM), a beta-blocker approved for the treatment of hypertension, launched in late January 2008, were $29.7 million, just under a twofold increase from the quarter a year ago. Contract revenue of $55.2 million declined 8.2%, principally from the Benicar(R) (olmesartan medoxomil) co-promotion income of $50.5 million, which declined 13.2% compared to last year. Per the agreement with Daiichi Sankyo, active co-promotion of Benicar ended in the first quarter of fiscal 2009 and the Company now receives a gradually reducing residual royalty until the end of March 2014. Interest income of $12.7 million decreased from $31.1 million reported in the prior year, due to lower interest rates earned on the Company's short duration portfolio. Other income was essentially unchanged at $0.8 million. Net revenues for the quarter, which includes net sales, contract revenue, interest and other income, were $965.5 million, a decrease of 2.6% from $990.9 million in the prior fiscal year.

Selling, general and administrative expenses during the quarter increased 57.3% to $515.1 million from $327.4 million last year and included a charge of $170.0 million related to the USAO investigation as well as significant expenses associated with the launch of Bystolic and pre-launch spending for Savella(TM), a selective serotonin norepinephrine dual reuptake inhibitor (SNRI) indicated for the management of fibromyalgia that was approved in Januar
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
3. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
4. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
5. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
6. Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video
7. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
8. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
9. United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
10. Old-Growth Forests Dying Off in U.S. West
11. Forest Laboratories, Inc. Reports Q309 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 CarePoint Health is proud to ... New Jersey to receive the da Vinci® Xi™ Surgical ... the da Vinci series. This 4th generation robotic platform ... in innovation. The intuitive da Vinci Xi has broad ... of minimally invasive and complex surgical procedures. The acquisition ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
(Date:7/23/2014)... its latest blog post, Best Drug Rehabilitation , which ... during a stay in rehab can make a big difference ... on a topic that is quickly becoming among the most ... , The Best Drug Rehabilitation blog post on opiate abuse ... and why they’re considered “the mother of all Schedule II ...
(Date:7/23/2014)... The Europe Drilling fluid and Completion fluid Market Report defines ... Europe with analysis and forecast of revenue. The drilling fluid ... from around $1.3 billion in 2013 to $1.7 billion by ... , Browse through the TOC of the Europe drilling fluid ... the in-depth analysis provided. This also provides a glimpse of ...
(Date:7/23/2014)... 23, 2014 AidJoy is delighted to announce ... Zen on September 5, 2014 from 7:00 to ... supporters are expected to attend this semi-formal event. , "We ... the past six years," says Jess Dennis, Director of Operations ... reflect on this moment in AidJoy’s history before we launch ...
Breaking Medicine News(10 mins):Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2
... Coaching Provides Caregiving Needed Resources and Coping Strategies , ... ... Leeza’s Place have teamed to provide online coaching for ... strategies. , , , , ,Working on concepts in “Take ...
... Networks, has joined Medeguide.com as Head of Advertising and Sponsorship ... ... Conrad, formerly Regional Managing Director for Admax Networks, has joined ... Medeguide,s online advertising and sponsorship activities. Medeguide is a new ...
... of information on multiple sclerosis medications and the financial help ... ... 2009 -- NeedyMeds, a national nonprofit, added a new resource page to ... page is a multiple sclerosis-specific source of help for those looking for ...
... Vega Tapped to Lead Health Care Improvement Firm,s Sales ... Associates, Inc. today announced the addition of Al Vega ... officer. Mr. Vega joins the company at a time ... sales and marketing efforts for the company. In particular, ...
... 20 The following is a statement of ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO )The Campaign ... (D-OR) for his leadership role in Senate committee ... and Drug Administration (FDA) regulatory authority over tobacco ...
... The following is a statement of Matthew ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO )The Campaign for ... for his leadership role in Senate committee approval ... Drug Administration (FDA) regulatory authority over tobacco products, ...
Cached Medicine News:Health News:Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First” 2Health News:Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First” 3Health News:Senior Advertising Executive Joins Medeguide 2Health News:New Source of Information on Multiple Sclerosis Medications 2Health News:Press Ganey Names Chief Sales and Marketing Officer 2Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 2Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 3Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 2Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 3
(Date:7/23/2014)... 2014  Researchers from the North American Menopause Society ... calcium levels too high, 1 putting women at ... Women close to menopause are commonly told to ... diseases such as osteoporosis, to which they are particularly ... how much calcium they typically get through their food ...
(Date:7/23/2014)... ORLANDO, Fla. , July 23, 2014 /PRNewswire/ ... with Pharm Fresh Media. This integration provides pharmacies ... media to current and prospective patients. ... pharmacy and local consumer data to define target ... provides automated marketing capabilities available within the Digital ...
(Date:7/23/2014)... Global healthcare company GSK reports ... headwinds, increased price competition and supply disruptions to its ... points out that the company is very much in ... be confident about long-term prospects as well as the ... CFO Simon Dingemans adds that the company ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... SPRINGS, Fla., Sept. 28 Tigris Pharmaceuticals, Inc., a ... the appointment of Mr. Neil Flanzraich as Executive Chairman ... of Mr. Flanzraich is a very important milestone for ... and CEO of Tigris, adding, "Neil brings to Tigris ...
... Research Group (MRG), the global authority on medical technology ... valued at $41 million in 2010, with revenues doubling ... issues surrounding obesity, coupled with an expanding patient pool ... growth in the gastric band market through 2015. This ...
Cached Medicine Technology:Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board 2Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board 3While Ethicon Endo-Surgery and Allergan Remain Front-Runners in the $41 Million Gastric Band Market, Other Competitors Battle for Third Place, According to Millennium Research Group 2
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
Medicine Products: